Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Oct 17, 2022
- Accession no.
- 0001209191-22-053717
- Filed
- Oct 17, 2022, 7:14 AM ET
- Trade date
- Oct 14, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $171.9K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2022 | Common Stock | PPurchaseAcquired | +30,214 | $1.72 | +$51,817.01 | 198,061,908 | Indirect | |
| Oct 14, 2022 | Common Stock | PPurchaseAcquired | +60,300 | $1.72 | +$103,716 | 198,122,208 | Indirect | |
| Oct 14, 2022 | Common Stock | PPurchaseAcquired | +8,086 | $1.73 | +$13,948.35 | 198,130,294 | Indirect | |
| Oct 14, 2022 | Common Stock | PPurchaseAcquired | +1,400 | $1.74 | +$2,436 | 198,131,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.